Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.055
Filtrar
1.
J Infect Dev Ctries ; 18(3): 480-487, 2024 Mar 31.
Artigo em Inglês | MEDLINE | ID: mdl-38635607

RESUMO

INTRODUCTION: Iatrogenic botulism is a rare, serious disease that progresses with descending paralysis and develops after cosmetic or therapeutic botulinum toxin-A (BoNT-A) application. CASE PRESENTATIONS: In this case series; six cases of iatrogenic botulism followed up in our center are presented. Four of these developed after gastric BoNT-A and two after axillary BoNT-A application. RESULTS: The most important cause for the disease was the use of unlicensed products and high-dose toxin applications. The first symptoms were blurred vision, double vision, difficulty in swallowing, and hoarseness. Symptoms appeared within 4-10 days after the application of BoNT-A. Symptoms progressed in the course of descending paralysis in the following days with fatigue, weakness in extremities and respiratory distress. Diagnosis was based on patient history and clinical findings. The main principles of foodborne botulism therapy were applied in the treatment of iatrogenic botulism. If clinical worsening continued, regardless of the time elapsed after BoNT-A application, the use of botulinum antitoxin made a significant contribution to clinical improvement and was recommended. CONCLUSIONS: Routine and new indications for BoNT-A usage are increasing and, as a result, cases of iatrogenic botulism will be encountered more frequently. Physicians should be alert for iatrogenic botulism in the follow-up after BoNT-A applications and in the differential diagnosis of neurological diseases that are presented with similar findings.


Assuntos
Toxinas Botulínicas Tipo A , Toxinas Botulínicas , Botulismo , Clostridium botulinum , Humanos , Toxinas Botulínicas/uso terapêutico , Botulismo/diagnóstico , Botulismo/tratamento farmacológico , Botulismo/etiologia , Antitoxina Botulínica/uso terapêutico , Paralisia/complicações , Paralisia/tratamento farmacológico , Doença Iatrogênica , Toxinas Botulínicas Tipo A/efeitos adversos
2.
Tidsskr Nor Laegeforen ; 144(2)2024 02 13.
Artigo em Inglês, Norueguês | MEDLINE | ID: mdl-38349108

RESUMO

This case study describes severe iatrogenic botulism following treatment with a botulinum toxin injection at a private clinic abroad.


Assuntos
Toxinas Botulínicas Tipo A , Botulismo , Clostridium botulinum , Humanos , Botulismo/diagnóstico , Botulismo/etiologia , Botulismo/terapia , Instituições de Assistência Ambulatorial , Doença Iatrogênica
3.
Zhonghua Er Ke Za Zhi ; 62(3): 218-222, 2024 Mar 02.
Artigo em Chinês | MEDLINE | ID: mdl-38378282

RESUMO

Objective: To summarize the clinical characteristics and prognosis of severe infant botulism and evaluate the therapeutic effect of botulinum antitoxin in the pediatric intensive care unit (PICU). Methods: The clinical data of 8 cases diagnosed with infantile botulism were retrospectively analyzed in the PICU of Beijing Children's Hospital from October 2019 to August 2023. Data of basic demographic information, clinical manifestations, laboratory tests, treatment and prognosis of each child were collected and analyzed using descriptive statistical methods. Results: Eight laboratory-confirmed cases of infant botulism were included in this study, all of which were male infants with an age of 6.0 (3.3,6.8) months. Three of the children were from Inner Mongolia Autonomous Region, 2 of them were from Hebei, and the other 3 were from Beijing, Shandong and Xinjiang Uyghur Autonomous Region, respectively. All the patients were previously healthy. In 4 of these cases, the possible cause was the ingestion of either honey and its products or sealed pickled food by the mother or child before the onset of the disease. The first symptom was poor milk intake (4 cases), followed by shallow shortness of breath (7 cases), limb weakness (7 cases) and so on. The typical signs were bilateral dilated pupils (8 cases) and decreased limb muscle strength (8 cases). The main subtype was type B (7 cases), and only 1 case was classified as type A. Six of the children were treated with antitoxin therapy for a duration of 24 (19, 49) d. Seven of them had invasive mechanical ventilation. All the patients survived upon discharge with a follow-up period of 29 d to 3 years and 8 months. Six patients had fully recovered, and 2 recently discharged patients were gradually recovering. Conclusions: For infants with suspected contact or ingestion of botulinum and presented with bilateral pupillary paralysis, muscle weakness and clear consciousness, the stool should be collected for diagnostic testing using a mouse bioassay as soon as possible. Type B was the most common type. The antitoxin treatment was effectiveness and the prognosis was well.


Assuntos
Antitoxinas , Toxinas Botulínicas , Botulismo , Criança , Lactente , Feminino , Humanos , Masculino , Botulismo/diagnóstico , Botulismo/terapia , Estudos Retrospectivos , Toxinas Botulínicas/uso terapêutico , Prognóstico , Antitoxinas/uso terapêutico
4.
Euro Surveill ; 28(47)2023 11.
Artigo em Inglês | MEDLINE | ID: mdl-37997664

RESUMO

In September 2023, a severe outbreak of type B botulism with fifteen cases was linked to consumption of canned sardines at a restaurant in Bordeaux, France, during the Rugby World Cup. The cases were from seven countries. One death was recorded. Outbreak investigation using credit card data, rapid communication between health authorities of the affected countries and broad media communication allowed identification of cases and exposed persons and prevented further severe outcomes.


Assuntos
Botulismo , Clostridium botulinum , Humanos , Botulismo/diagnóstico , Botulismo/epidemiologia , Rugby , Surtos de Doenças , França/epidemiologia
5.
Ann Med ; 55(2): 2279746, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37943711

RESUMO

BACKGROUND: Botulism is a rare disease, and infant botulism (IB) even rarer, especially when steering the condition to honey consumption. IB is considered a life-threatening disease as it leads to severe neurological symptoms. Exploring the knowledge, attitude, and practice (KAP) among mothers on the relationship between honey and IB will help public health professionals implement appropriate maternal health education materials targeting infant health and increase the awareness of the paediatric primary care providers, physicians, and nurse practitioners about the risk of IB among their patients. OBJECTIVES: To determine the knowledge of mothers from Hail city in Saudi Arabia (SA) regarding IB and assess their attitude and practice towards feeding honey to their infants before 12 months of age. METHODS: Using a comparative cross-sectional study, in February 2022, we broadcasted an online questionnaire through social networking and evaluated the KAP of 385 mothers. RESULTS: Less than half (48%) of the mothers have heard about IB, 40% of them knew the relation between honey ingestion and IB and only 6.5% acknowledged that they knew the causative agent for IB. The prevalence of feeding honey to infants before 12 months was 52%. Mothers from Hail city were less likely to provide honey to their infants (p = 0.002). CONCLUSION: The study revealed that mothers from Hail city have relatively low knowledge of IB and that they hold favourable perceptions of using honey as a food supplement and feeding honey to their infants before 12 months. Considering the high prevalence of honey feeding with the known low incidence of IB in SA, Medical professionals should consider IB in their differential diagnosis particularly in the presence of neurological symptoms.


Assuntos
Botulismo , Mel , Feminino , Humanos , Lactente , Criança , Botulismo/diagnóstico , Botulismo/epidemiologia , Botulismo/etiologia , Arábia Saudita/epidemiologia , Estudos Transversais , Conhecimentos, Atitudes e Prática em Saúde
6.
Przegl Epidemiol ; 77(2): 233-240, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37860971

RESUMO

Objectives: The aim of this study is to assess the epidemiological situation of foodborne botulism in Poland in 2018-2021, compared to previous years. Materials and methods: The assessment is based on an analysis of aggregated surveillance data from the annual bulletin "Infectious Diseases and Poisons in Poland" from 2013-2021, as well as botulism case reports collected by sanitary-epidemiological stations and sent to the Department of Epidemiology of Infectious Diseases and Surveillance of the NIPH NIH - NRI or provided by EpiBase. Results: A total of 54 foodborne botulism cases were registered between 2018 and 2021, including 31 (57.4%) cases of laboratory-confirmed botulism intoxication. Most cases (46 cases, 85.2%) were sporadic. The declining trend in the number of notifications continued throughout the time period, and the incidence recorded in 2021 (0.02 per 100,000 population) was the lowest since the introduction of mandatory reporting and registration of botulism in Poland. The highest median annual incidence was recorded in the Warmisko-Mazurskie (0.18), but many voivodeships reported only single notifications or none. The decreasing trend in rural areas relative to the level of incidence in urban areas continued. Men (incidence in men more than twice that of women) and people aged 50-59 predominated. All patients were hospitalized. According to the State Sanitary Inspection, there were 3 deaths (mortality of 5.6%). Conclusions: In 2018-2021, the downward trend in the number of foodborne botulism notifications in Poland continued. At the same time, the considerable proportion of cases reported by physicians without laboratory confirmation and not meeting the definition of botulism adopted in other EU countries is noteworthy. The incidence in rural areas decreases to the level of incidence in urban areas, and the previously observed geographical distribution of cases diminishes.


Assuntos
Botulismo , Doenças Transmissíveis , Masculino , Humanos , Feminino , Lactente , Botulismo/diagnóstico , Botulismo/epidemiologia , Polônia/epidemiologia , Surtos de Doenças , Sistema de Registros , População Rural , População Urbana , Distribuição por Idade , Doenças Transmissíveis/epidemiologia , Incidência
7.
Toxicon ; 235: 107326, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37871760

RESUMO

Food-borne botulism is a rare but potentially fatal illness. Its management depends on rapid diagnosis and prompt antitoxin administration. However, diagnosing food-borne botulism can be challenging at an early stage. Here, we report a 62-year-old male with food-borne botulism. The patient presented with extremity muscle weakness, dyspnea, bilateral droopy eyelids (more significant on the right side), dysarthria, and progressive dysphagia. The electromyography indicated presynaptic membrane abnormalities. The toxicology screen reported a positive result for botulinum toxin type A. He received plasma exchange, botulism antitoxin, and supportive care. However, he had a cardiac arrest six days later. Spontaneous circulation was restored after immediate cardiopulmonary resuscitation. The patient gradually recovered his muscle strength and could have complete eyelid elevation. A detailed interview revealed that six family members developed similar symptoms. All of them consumed a homemade sauce prepared three years ago. They all tested positive for botulinum toxin type A. Two of them had cardiac arrests. Therefore, family aggregation could happen to botulism. Careful interviews, early diagnosis, and timely administration of botulism antitoxin are the keys to saving lives. Special attentions should be given to the cardiac evaluations since botulism can cause cardiac arrest and death.


Assuntos
Toxinas Botulínicas Tipo A , Botulismo , Parada Cardíaca , Masculino , Humanos , Pessoa de Meia-Idade , Botulismo/diagnóstico , Botulismo/etiologia , Antitoxina Botulínica , Parada Cardíaca/induzido quimicamente , Parada Cardíaca/complicações
8.
J Med Case Rep ; 17(1): 401, 2023 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-37679840

RESUMO

BACKGROUND: Clostridium botulinum is an anaerobic, Gram-positive, rod-shaped bacterium that forms spores and the neurotoxin botulinum. It is best known for its toxin-induced flaccid paralytic disease, which is deadly without correct treatment. In this report, we show a completely different clinical course with fatal outcome. CASE PRESENTATION: A 37-year-old African man born in Sierra Leone was admitted. After admission, his condition rapidly worsened due to severe septic shock and progressive multiorgan failure. No neurological signs were seen. Despite treatment with antibiotics, fluid resuscitation, and norepinephrine, the multiorgan failure deteriorated further and he died as a result. Blood and synovial fluid cultures showed Clostridium botulinum. No botulinum toxins were found. CONCLUSION: This is a rare case of fatal septic shock due to Clostridium botulinum-induced septic arthritis without any sign of the classic clinical syndrome of botulism.


Assuntos
Toxinas Botulínicas , Botulismo , Clostridium botulinum , Choque Séptico , Masculino , Humanos , Adulto , Choque Séptico/tratamento farmacológico , Insuficiência de Múltiplos Órgãos , Botulismo/diagnóstico
9.
Int J Infect Dis ; 136: 111-114, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37741312

RESUMO

OBJECTIVES: Botulism is a rare syndrome characterized by acute, flaccid paralysis with possible involvement of respiratory muscle-producing pump failure requiring mechanical ventilation. A predominance of autonomic involvement can occur. METHODS: We enrolled patients affected by foodborne botulism during an outbreak. All patients underwent the detection of the toxin in stool specimens, and 24-hour ambulatory blood pressure monitoring (ABPM). A blinded expert operator analyzed ABPM data for the diagnosis of hypertension and postprandial hypotension (PPH). RESULTS: Twenty male patients met the inclusion and exclusion criteria. Thirty-four healthy subjects matched for sex and age were enrolled as a control group. PPH was significantly more frequent in the botulin group than in healthy subjects (40% vs 2.9%, P <0.0001). At the logistic regression, the probability that patients affected by botulinum could require ventilation was increased by 733% (adjusted odds ratio: 8.33) when PPH is encountered. CONCLUSIONS: The likelihood of resorting to ventilation in subjects with botulinum intoxication was seven times greater in patients presenting PPH. These results could allow the prompt identification of patients at high risk for requiring ventilation.


Assuntos
Botulismo , Hipotensão , Insuficiência Respiratória , Humanos , Masculino , Monitorização Ambulatorial da Pressão Arterial , Estudos de Casos e Controles , Hipotensão/etiologia , Hipotensão/epidemiologia , Botulismo/diagnóstico , Botulismo/epidemiologia , Insuficiência Respiratória/epidemiologia , Insuficiência Respiratória/etiologia , Surtos de Doenças
10.
Emerg Infect Dis ; 29(9)2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37610295

RESUMO

During 2006-2021, Canada had 55 laboratory-confirmed outbreaks of foodborne botulism, involving 67 cases. The mean annual incidence was 0.01 case/100,000 population. Foodborne botulism in Indigenous communities accounted for 46% of all cases, which is down from 85% of all cases during 1990-2005. Among all cases, 52% were caused by botulinum neurotoxin type E, but types A (24%), B (16%), F (3%), and AB (1%) also occurred; 3% were caused by undetermined serotypes. Four outbreaks resulted from commercial products, including a 2006 international outbreak caused by carrot juice. Hospital data indicated that 78% of patients were transferred to special care units and 70% required mechanical ventilation; 7 deaths were reported. Botulinum neurotoxin type A was associated with much longer hospital stays and more time spent in special care than types B or E. Foodborne botulism often is misdiagnosed. Increased clinician awareness can improve diagnosis, which can aid epidemiologic investigations and patient treatment.


Assuntos
Botulismo , Humanos , Botulismo/diagnóstico , Botulismo/epidemiologia , Canadá/epidemiologia , Surtos de Doenças , Hospitais , Laboratórios
11.
Klin Mikrobiol Infekc Lek ; 29(1): 26-28, 2023 Mar.
Artigo em Tcheco | MEDLINE | ID: mdl-37586089

RESUMO

In the Czech Republic, botulism is a rare life-threatening disease. A total of 155 cases have been reported since 1960; according to the ISIN (formerly EPIDAT) database, there have been only three isolated cases since 2013, with the exception of a single occurrence of familial botulism in 2013. In our work, we present the occurrence of botulism after ingestion of pâté of untraceable origin by a couple who were hospitalized for botulotoxin food poisoning in July 2022. Their neurological symptoms were dominated by dysarthria. After administration of antibotulinum serum, their condition improved significantly. Patient samples were analyzed using affinity carriers and MALDI mass spectrometry, a modern highly sensitive technique for detecting the presence of botulinum neurotoxins. Unlike traditional detection by a difficult and costly biological experiment on mice, the above analysis does not require the killing of laboratory animals.


Assuntos
Toxinas Botulínicas , Botulismo , Clostridium botulinum , Camundongos , Animais , Botulismo/diagnóstico , Botulismo/epidemiologia , Neurotoxinas , República Tcheca/epidemiologia , Toxinas Botulínicas/análise
12.
JAMA ; 330(1): 90, 2023 07 03.
Artigo em Inglês | MEDLINE | ID: mdl-37395771

RESUMO

This JAMA Patient Page describes botulism routes of infection, symptoms, diagnosis, treatment, and prevention measures.


Assuntos
Botulismo , Humanos , Botulismo/diagnóstico , Botulismo/terapia
13.
J Clin Apher ; 38(6): 760-763, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37519071

RESUMO

Guillain-Barré syndrome (GBS) is an immune-mediated polyradiculoneuropathy and the most common cause of acute flaccid paralysis worldwide. GBS classically presents with acute, progressive, ascending weakness, reduced to absent reflexes, and albuminocytological dissociation on cerebrospinal fluid (CSF) analysis. Botulism is a neurotoxin-mediated acute descending flaccid paralysis with cranial nerve palsies and dysautonomia. Botulism in adults is caused by ingestion/inhalation of botulinum toxin or wound infection with Clostridium botulinum. Both GBS and botulism can rapidly precipitate respiratory failure; thus, prompt diagnosis and treatment are crucial to mitigate poor outcomes. Herein, we describe a case of botulism initially diagnosed as GBS given classic laboratory features, and describe the importance of careful consideration of the most appropriate therapeutic modalities in cases of acute flaccid paralysis, particularly regarding empiric administration of botulinum antitoxin and use of intravenous immune globulin in lieu of plasma exchange for potential GBS to prevent removal of antitoxin.


Assuntos
Botulismo , Síndrome de Guillain-Barré , Adulto , Humanos , Botulismo/diagnóstico , Botulismo/terapia , Botulismo/etiologia , Síndrome de Guillain-Barré/diagnóstico , Síndrome de Guillain-Barré/terapia , Síndrome de Guillain-Barré/complicações , Troca Plasmática/efeitos adversos , Paralisia/complicações , Paralisia/terapia
14.
Pediatr Neurol ; 146: 40-43, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37429225

RESUMO

Infantile botulism is an uncommon diagnosis and rarer still in the neonatal period. We describe three cases of neonatal-onset botulism that presented with symptoms typically (hypotonia, constipation, facial diplegia) or atypically seen in older infants (encephalopathy, seizures, and hypothermia). Our series shows a wider spectrum of clinical presentations in patients with neonatal-onset botulism. Our report also suggests that neonatal-onset botulism should be considered more broadly in the hypotonic infant, especially as the condition is treatable with intravenous botulinum-specific immune globulin.


Assuntos
Botulismo , Clostridium botulinum , Doenças do Recém-Nascido , Lactente , Recém-Nascido , Humanos , Idoso , Botulismo/diagnóstico , Botulismo/terapia , Anticorpos , Imunoglobulinas Intravenosas/uso terapêutico
15.
Euro Surveill ; 28(23)2023 06.
Artigo em Inglês | MEDLINE | ID: mdl-37289431

RESUMO

In March 2023, 34 associated cases of iatrogenic botulism were detected in Germany (30 cases), Switzerland (two cases), Austria (one case), and France (one case). An alert was rapidly disseminated via European Union networks and communication platforms (Food- and Waterborne Diseases and Zoonoses Network, EpiPulse, Early Warning and Response System) and the International Health Regulation mechanism; the outbreak was investigated in a European collaboration. We traced sources of the botulism outbreak to treatment of weight loss in Türkiye, involving intragastric injections of botulinum neurotoxin. Cases were traced using a list of patients who had received this treatment. Laboratory investigations of the first 12 German cases confirmed nine cases. The application of innovative and highly sensitive endopeptidase assays was necessary to detect minute traces of botulinum neurotoxin in patient sera. The botulism notification requirement for physicians was essential to detect this outbreak in Germany. The surveillance case definition of botulism should be revisited and inclusion of cases of iatrogenic botulism should be considered as these cases might lack standard laboratory confirmation yet warrant public health action. Any potential risks associated with the use of botulinum neurotoxins in medical procedures need to be carefully balanced with the expected benefits of the procedure.


Assuntos
Toxinas Botulínicas , Botulismo , Clostridium botulinum , Animais , Humanos , Toxinas Botulínicas/efeitos adversos , Botulismo/diagnóstico , Botulismo/epidemiologia , Botulismo/etiologia , Neurotoxinas , Viagem , Surtos de Doenças , Redução de Peso , Doença Iatrogênica/epidemiologia
16.
Arch. argent. pediatr ; 121(3): e202202656, jun. 2023.
Artigo em Inglês, Espanhol | LILACS, BINACIS | ID: biblio-1435629

RESUMO

Introducción. El botulismo del lactante (BL) es la forma más frecuente de botulismo humano en Argentina. El objetivo es describir aspectos esenciales del diagnóstico y tratamiento de pacientes con BL internados en el servicio de terapia intensiva pediátrica (STIP). Métodos. Estudio observacional, descriptivo y retrospectivo. Se utilizó la base de datos del STIP con diagnóstico de BL en el período 2005-2020. Se registraron variables demográficas, métodos de diagnóstico, días de asistencia respiratoria mecánica convencional (ARMC), de ventilación no invasiva (VNI), estadía en STIP, mortalidad al alta hospitalaria. Resultados. Se registraron 21 pacientes con BL; 14 pacientes fueron varones, con una mediana de edad de 5 meses (RIC 2-6 m). El diagnóstico se realizó mediante técnica de bioensayo y se detectó la toxina en suero en 12 pacientes. Uno solo no requirió ARMC; 1 paciente fue traqueostomizado; 18 pacientes recibieron antibióticos; 5 recibieron VNI. Ningún paciente recibió antitoxina y no hubo fallecidos. La mediana de estadía hospitalaria fue 66 días (RI: 42-76); de internación en STIP, 48 días (RI: 29-78); y de ARMC, 37 días (RI: 26-64). La demora en la confirmación diagnóstica fue 15,8 ± 4,8 días. Conclusiones. La totalidad de los pacientes fueron diagnosticados con la técnica de bioensayo, que generó un tiempo de demora diagnóstica que excede los lapsos recomendados para la administración del tratamiento específico. Ningún paciente recibió tratamiento específico. El BL presentó baja mortalidad, pero tiempos de ARM e internación prolongados, que se asocian a infecciones sobreagregadas y uso frecuente de antibióticos.


Introduction. Infant botulism (IB) is the most common form of human botulism in Argentina. Our objective was to describe the main aspects of diagnosis and management of patients with IB admitted to the pediatric intensive care unit (PICU). Methods. Observational, descriptive, and retrospective study. The PICU database with IB diagnosis in 2005­2020 period was used. Demographic variables, diagnostic methods, days of conventional mechanical ventilation (CMV), non-invasive ventilation (NIV), length of stay in the PICU and mortality upon hospital discharge were recorded. Results. In total, 21 patients with IB were recorded; 14 were male, their median age was 5 months (IQR: 2­6 m). Diagnosis was made by bioassay, and the toxin was identified in the serum of 12 patients. Only 1 patient did not require CMV; 1 patient had a tracheostomy; 18 patients received antibiotics; 5 received NIV. No patient was administered antitoxin and no patient died. The median length of stay in the hospital was 66 days (IQR: 42­76); in the PICU, 48 days (IQR: 29­78); and the median use of CMV, 37 days (IQR: 26­64). The delay until diagnostic confirmation was 15.8 ± 4.8 days. Conclusions. All patients were diagnosed using the bioassay technique, which resulted in a diagnostic delay that exceeds the recommended period for the administration of a specific treatment. No patient received a specific treatment. IB was related to a low mortality, but also to prolonged use of MV and length of hospital stay, which were associated with cross infections and frequent antibiotic use.


Assuntos
Humanos , Masculino , Feminino , Lactente , Botulismo/diagnóstico , Botulismo/terapia , Botulismo/epidemiologia , Infecções por Citomegalovirus , Respiração Artificial , Unidades de Terapia Intensiva Pediátrica , Estudos Retrospectivos , Diagnóstico Tardio , Antibacterianos
18.
J Pediatr ; 258: 113396, 2023 07.
Artigo em Inglês | MEDLINE | ID: mdl-37004956

RESUMO

This study sought to determine duration of fecal excretion of Clostridium botulinum organisms and neurotoxin after onset of infant botulism in 66 affected infants. Median excretion was longer for type A than type B patients (organisms: 5.9 vs 3.5 weeks, toxin: 4.8 vs 1.6 weeks, respectively). Toxin excretion always ceased before organism excretion. Antibiotic therapy did not affect duration of excretion.


Assuntos
Toxinas Botulínicas , Botulismo , Clostridium botulinum , Lactente , Humanos , Botulismo/diagnóstico , Botulismo/tratamento farmacológico , Fezes , Clostridium
19.
J Med Case Rep ; 17(1): 139, 2023 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-37060100

RESUMO

BACKGROUND: Botulism is a rare neuroparalytic disease that has only presented itself 19 times in the last 30 years in Belgium. Patients present to emergency services with a wide range of complaints. Foodborne botulism is a forgotten yet life-threatening disease. CASE PRESENTATION: We describe a case of a Caucasian female in her 60s that presented to the emergency with reflux with nausea and spasmodic epigastric pain, no vomiting, dry mouth, and weakness in both legs. The symptoms started after ingestion of Atlantic wolffish. After exclusion of other more common causes, foodborne botulism was suspected. The patient was admitted to the intensive care unit for mechanical ventilation. Following treatment with trivalent botulinum antitoxin, she made a full neurologic recovery. CONCLUSION: It is important to rapidly recognize the possible diagnosis of botulism even if the neurological symptoms are not dominant. Rapid neurologic dysfunction and respiratory difficulties starts between 6 and 72 hours after ingestion. The decision to administer antitoxins should, however, be based on the presumptive clinical diagnosis and diagnosis should not delay therapy.


Assuntos
Botulismo , Humanos , Feminino , Botulismo/diagnóstico , Botulismo/terapia , Botulismo/etiologia , Antitoxina Botulínica/uso terapêutico , Serviço Hospitalar de Emergência , Dispneia , Respiração Artificial , Doenças Raras
20.
Clin Neuropharmacol ; 46(2): 82-84, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36728838

RESUMO

OBJECTIVE: Botulinum toxin type A is widely used for the treatment of spasticity, focal dystonia, hemifacial spasm, hyperhidrosis, strabismus, chronic migraine, and also cosmetic purposes. Therapeutic use is commonly effective and safe. However, if toxin enters the vascular space and gets through to peripheral cholinergic nerve terminals, it may lead to iatrogenic botulism. METHOD: We presented a patient who is diagnosed as iatrogenic botulism and treated with antitoxin at the 15th day of the exposure. RESULTS: After the antitoxin administration, dramatical response to the treatment was observed. CONCLUSIONS: In this report, we want to evaluate a new case of iatrogenic botulism and emphasize the importance of antitoxin administration regardless the timing of the exposure for patients with progressing paralysis.


Assuntos
Antitoxinas , Toxinas Botulínicas Tipo A , Botulismo , Humanos , Antitoxinas/uso terapêutico , Antitoxina Botulínica/uso terapêutico , Toxinas Botulínicas Tipo A/efeitos adversos , Botulismo/tratamento farmacológico , Botulismo/diagnóstico , Doença Iatrogênica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...